AT301537B - Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen

Info

Publication number
AT301537B
AT301537B AT229671A AT229671A AT301537B AT 301537 B AT301537 B AT 301537B AT 229671 A AT229671 A AT 229671A AT 229671 A AT229671 A AT 229671A AT 301537 B AT301537 B AT 301537B
Authority
AT
Austria
Prior art keywords
salts
production
imidazole derivatives
new imidazole
new
Prior art date
Application number
AT229671A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT301537B publication Critical patent/AT301537B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
AT229671A 1970-03-23 1971-03-17 Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen AT301537B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2013793A DE2013793C2 (de) 1970-03-23 1970-03-23 N-Methyl-imidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
AT301537B true AT301537B (de) 1972-09-11

Family

ID=5765958

Family Applications (1)

Application Number Title Priority Date Filing Date
AT229671A AT301537B (de) 1970-03-23 1971-03-17 Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen

Country Status (21)

Country Link
US (1) US3787415A (de)
JP (2) JPS5414107B1 (de)
AT (1) AT301537B (de)
BE (1) BE764700A (de)
CA (1) CA971964A (de)
CH (1) CH558802A (de)
DE (1) DE2013793C2 (de)
DK (1) DK143847C (de)
ES (2) ES389495A1 (de)
FI (1) FI55338C (de)
FR (1) FR2085731B1 (de)
GB (1) GB1288196A (de)
HU (1) HU162527B (de)
IE (1) IE35137B1 (de)
IL (1) IL36272A0 (de)
NL (1) NL171269C (de)
NO (1) NO130536C (de)
SE (1) SE369602B (de)
SU (1) SU411688A3 (de)
YU (1) YU34476B (de)
ZA (1) ZA711268B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928348A (en) * 1970-03-23 1975-12-23 Bayer Ag N-methyl-imidazole derivatives and their production
US4062959A (en) * 1970-03-23 1977-12-13 Bayer Aktiengesellschaft N-methyl-imidazole derivatives for treating mycotic infections
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4384165A (en) * 1981-09-14 1983-05-17 Motorola, Inc. Radio frequency shield with force multiplier interconnection fingers for an electromagnetic gasket
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6915465D0 (pt) * 1969-03-07 1973-01-04 Bayer Ag Processo para preparar n-benzimidazois substituidos na posicao alfa por heterociclos penta-membrados com atividade antimicotica

Also Published As

Publication number Publication date
IL36272A0 (en) 1971-04-28
US3787415A (en) 1974-01-22
HU162527B (de) 1973-03-28
FI55338C (fi) 1979-07-10
DE2013793A1 (de) 1971-10-28
JPS554754B1 (de) 1980-01-31
ES391297A1 (es) 1973-07-01
BE764700A (fr) 1971-09-23
FI55338B (fi) 1979-03-30
CA971964A (en) 1975-07-29
JPS5414107B1 (de) 1979-06-05
ZA711268B (en) 1971-11-24
SE369602B (de) 1974-09-09
FR2085731A1 (de) 1971-12-31
NO130536C (de) 1975-01-08
NL171269C (nl) 1983-03-01
CH558802A (de) 1975-02-14
DE2013793C2 (de) 1983-02-03
NO130536B (de) 1974-09-23
ES389495A1 (es) 1973-06-01
SU411688A3 (de) 1974-01-15
NL171269B (nl) 1982-10-01
FR2085731B1 (de) 1974-09-27
GB1288196A (de) 1972-09-06
DK143847B (da) 1981-10-19
IE35137B1 (en) 1975-11-26
DK143847C (da) 1982-04-05
IE35137L (en) 1971-09-23
YU70171A (en) 1979-02-28
YU34476B (en) 1979-09-10
NL7103889A (de) 1971-09-27

Similar Documents

Publication Publication Date Title
AT304536B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT315835B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT311337B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT319941B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT307398B (de) Verfahren zur Herstellung von neuen Pyrrolinderivaten und ihren Salzen
AT305276B (de) Verfahren zur Herstellung von neuen Isoindolinderivaten und ihren Salzen
AT303041B (de) Verfahren zur Herstellung von neuen Isochinolin-Derivaten und ihren Salzen
AT303022B (de) Verfahren zur Herstellung von neuen Dihydrofuranderivaten und ihren Salzen
AT309414B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT303721B (de) Verfahren zur Herstellung von neuen Dishenylmethyl-imidazolen und ihren Salzen
AT310153B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT301537B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT302291B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen
AT303035B (de) Verfahren zur Herstellung von neuen basischen Phenyl-azolyl-fettsäurederivaten und ihren Salzen
AT304561B (de) Verfahren zur Herstellung von neuen Phenazinderivaten und ihren Salzen
AT308098B (de) Verfahren zur Herstellung von neuen Imidazolinderivaten und ihren Salzen
AT308097B (de) Verfahren zur Herstellung von neuen Imidazolinderivaten und ihren Salzen
AT312594B (de) Verfahren zur Herstellung von neuen Indolderivaten und ihren Salzen
AT319231B (de) Verfahren zur Herstellung von neuen Pyrazolderivaten und ihren Salzen
AT304529B (de) Verfahren zur Herstellung von neuen Pyrrolderivaten und ihren Salzen
AT289094B (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten und ihren Salzen
AT309420B (de) Verfahren zur Herstellung von neuen Thiazolderivaten und ihren Salzen
AT305272B (de) Verfahren zur Herstellung von neuen Pyrrolidinderivaten und ihren Salzen
AT318611B (de) Verfahren zur Herstellung von neuen Tioxanthenderivaten und ihren Salzen
AT304537B (de) Verfahren zur Herstellung von neuen Imidazolderivaten und ihren Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee